Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.
Angelin Tresa Mathew, Bhav Jain, Edward Christopher Dee, Jordan Johnson, Fumiko Chino
Author Information
- Angelin Tresa Mathew: Yale University, New Haven, CT, USA.
- Bhav Jain: Massachusetts Institute of Technology, Cambridge, MA, USA.
- Edward Christopher Dee: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Jordan Johnson: Oncospark, Ashland, KY, USA.
- Fumiko Chino: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chinof@mskcc.org. ORCID
No abstract text available.
- CA Cancer J Clin. 2021 May;71(3):209-249
[PMID: 33538338]
- JAMA. 2021 Jun 4;:
[PMID: 34086052]
- J Natl Cancer Inst. 2015 Dec 11;108(5):
[PMID: 26657334]
- JAMA. 2021 Feb 23;325(8):715-716
[PMID: 33620413]
- JAMA. 2016 May 3;315(17):1874-81
[PMID: 27139060]
- P30 CA008748/NCI NIH HHS
- P30 CA008748/NIH HHS
Breast Neoplasms
Cancer Care Facilities
Female
Humans
National Cancer Institute (U.S.)
Neoplasms
United States
